Biomedical Textiles Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage:by Fiber Type (Non-Biodegradable Fiber, Biodegradable Fiber); Fabric Type (Woven, Non-Woven, Others); Application (Non-Implantable, Implantable, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

MARKET INTRODUCTION

Medical textiles involve textiles used in medical applications. These should be non-allergic, non-toxic, biocompatible, and non-carcinogenic. These are used in the manufacturing of a wide range of products such as bandages, wound care, pressure garments, prosthetic socks, adhesive tapes, protective eye pads, orthopedic belts, and others. Implantable biomedical textile is used in arterial grafts, artificial skin and other organs, sutures and ligatures, and synthetic repair fabrics. Hence, biomedical textiles can be categorized based on fibers, mainly designed for specific biological conditions.

MARKET DYNAMICS

Increasing diabetic foot ulcers, burn injuries, and surgeries are growing demand for wound care management product, in turn, driving the growth of the market. For instance, diabetes affects approximately 415 million people globally, the IDF Diabetes Atlas. Additionally, the risk of developing diabetic foot ulcers is about 34% in diabetic patients. Moreover, growing tissue engineering applications to create new tissue are further driving the growth of the biomedical textile market. A wide variety of biomedical textiles are being used routinely for healing. Some of them are cotton, silk, fiber yarns, collagen, synthetic fibers (polyethylene, polyester, and polyamide, polyurethane), and alginate, among others. These biomaterials are used for soft tissue repair, extracorporeal implants, health care and hygiene products, and other purposes as per their specificity. Furthermore, technological advancements in the medical textile industry are offering lucrative opportunities for the market.

MARKET SCOPE

The "Global Biomedical Textiles Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of biomedical textiles market with detailed market segmentation by fiber type, fabric type, application and geography. The global biomedical textiles market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading biomedical textiles market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global biomedical textiles market is segmented on the basis of fiber type, fabric type and application. Based on fiber type, the market is segmented as non-biodegradable fiber and biodegradable fiber. Non-biodegradable fiber segment is further sub segmented into polypropylene and polyethylene, cotton, polyester, polyamide and others. Biodegradable fiber segment is further sub divided into collagen, chitin and others. Based on fabric type, the market is segmented as woven, non-woven and others. Based on application, the market is segmented into non-implantable, implantable, extracorporeal devices, and healthcare and hygiene products.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global biomedical textiles market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The biomedical textiles market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting biomedical textiles market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the biomedical textiles market in these regions.

MARKET PLAYERS

The report covers key developments in the biomedical textiles market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from biomedical textiles market are anticipated to lucrative growth opportunities in the future with the rising demand for biomedical textiles market in the global market. Below mentioned is the list of few companies engaged in the biomedical textiles market.
The report also includes the profiles of key biomedical textiles market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  ATEX TECHNOLOGIES
•  Freudenberg Medical
•  Bally Ribbon Mills
•  Confluent Medical Technologies
•  Secant Group, LLC
•  Meister & Cie AG
•  Swicofil AG
•  Proxy Biomedical
•  US BioDesign
•  DSM

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Biomedical Textiles Report Scope

The List of Companies

1. ATEX TECHNOLOGIES
2. Freudenberg Medical
3. Bally Ribbon Mills
4. Confluent Medical Technologies
5. Secant Group, LLC
6. Meister & Cie AG
7. Swicofil AG
8. Proxy Biomedical
9. US BioDesign
10. DSM